A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.

MLA

Bardet, E., et al. “A Phase II Trial of Radiochemotherapy with Daily Carboplatin, after Induction Chemotherapy (Carboplatin and Etoposide), in Locally Advanced Nonsmall-Cell Lung Cancer: Final Analysis.” International Journal of Radiation Oncology, Biology, Physics, vol. 38, no. 1, Apr. 1997, pp. 163–68. EBSCOhost, https://doi.org/10.1016/s0360-3016(97)00254-x.

APA

Bardet, E., Rivière, A., Charloux, A., Spaeth, D., Ducoloné, A., Le Groumellec, A., Pellae-Cosset, B., Henry-Amar, M., & Douillard, J. Y. (1997). A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis. International Journal of Radiation Oncology, Biology, Physics, 38(1), 163–168. https://doi.org/10.1016/s0360-3016(97)00254-x

Chicago

Bardet, E, A Rivière, A Charloux, D Spaeth, A Ducoloné, A Le Groumellec, B Pellae-Cosset, M Henry-Amar, and J Y Douillard. 1997. “A Phase II Trial of Radiochemotherapy with Daily Carboplatin, after Induction Chemotherapy (Carboplatin and Etoposide), in Locally Advanced Nonsmall-Cell Lung Cancer: Final Analysis.” International Journal of Radiation Oncology, Biology, Physics 38 (1): 163–68. doi:10.1016/s0360-3016(97)00254-x.